ARCHIVES

Irinotecan And Carboplatin Improve Response In NSCLC

This article is from The Cancer Letter archive.

Vol. 28 No. 6 | June 24, 2005

Download PDF Visit The Full Archive

Related Articles

In Brief: Bruce Chamber Is DeVita’s Choice as Permanent Director Of DCT; Six New RCDAs Funded In FY 1982

June 11, 1982

Senate confirms Crawford as FDA commissioner.

July 22, 2005

Biomedical Supercomputer Will Be Available To NIH, Extramural Scientists; No Payback Planned To Starts

July 13, 1984

Moses To Lead AACI.

October 19, 2001

FDA News: Rule Limits Drug Pioneers To 30-Month Patent Extension

June 20, 2003

Recombinant Protein C Cuts Risk Of Sepsis Death

February 22, 2002